A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010

Journal of Autoimmunity

Volumn 50, Issue , 2014, Pages 99-106

  Lind, Alexander ^a   Ramelius, Anita ^a   Olsson, Tomas ^b   Arnheim Dahlström, Lisen ^b   Lamb, Favelle ^b   Khademi, Mohsen ^b   Ambati, Aditya ^b   Maeurer, Markus ^c   Nilsson, Anna Lena ^d   Bomfim, Izaura Lima ^b   Fink, Katharina ^b   Lernmark, Åke ^a  

^a LUND UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d ÖSTERSUND HOSPITAL   (Sweden)

Author keywords

06:02; A H1N1; Autoantibodies; Autoimmunity; HLA DQB1; Narcolepsy; Vaccination

Indexed keywords

AUTOANTIBODY; CYSTEINE; GLUTAMATE DECARBOXYLASE 65; HEMAGGLUTININ; HLA DQB1 ANTIGEN; INFLUENZA VACCINE; INFLUENZA VIRUS A H1N1 ANTIBODY; SULFUR 35; TRIBBLES HOMOLOG 2 AUTOANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY; GAD55, HUMAN; GLUTAMATE DECARBOXYLASE; HLA DQ ANTIGEN; HLA-DQB1 ANTIGEN; SIGNAL PEPTIDE; TRIB2 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMORAL IMMUNITY; IN VITRO STUDY; INFLUENZA VACCINATION; MALE; NARCOLEPSY; NUCLEOTIDE SEQUENCE; ONSET AGE; PRIORITY JOURNAL; SWEDEN; ANTAGONISTS AND INHIBITORS; BLOOD; CHEMICALLY INDUCED; GENE EXPRESSION; GENETICS; IMMUNOLOGY; INFLUENZA VIRUS A H1N1; INFLUENZA, HUMAN; MIDDLE AGED; PANDEMICS; PRESCHOOL CHILD; VACCINATION;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION; GLUTAMATE DECARBOXYLASE; HLA-DQ BETA-CHAINS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NARCOLEPSY; PANDEMICS; SWEDEN; VACCINATION;

EID: 84899093017     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2014.01.031     Document Type: Article

References (41)

1. Nohynek H., Jokinen J., Partinen M., Vaarala O., Kirjavainen T., Sundman J., et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One 2012, 7:e33536.
2. Akintomide G.S., Rickards H. Narcolepsy: a review. Neuropsychiatr Dis Treat 2011, 7:507-518.
3. Mignot E. Ahundred years of narcolepsy research. Arch Ital Biol 2001, 139:207-220.
4. Miller E., Andrews N., Stellitano L., Stowe J., Winstone A.M., Shneerson J., et al. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis. BMJ 2013, 346:f794.
5. Burgess C.R., Scammell T.E. Narcolepsy: neural mechanisms of sleepiness and cataplexy. JNeurosci 2012, 32:12305-12311.
6. Inutsuka A., Yamanaka A. The regulation of sleep and wakefulness by the hypothalamic neuropeptide orexin/hypocretin. Nagoya J Med Sci 2013, 75:29-36.
7. Taheri S., Zeitzer J.M., Mignot E. The role of hypocretins (orexins) in sleep regulation and narcolepsy. Annu Rev Neurosci 2002, 25:283-313.
8. Overeem S., Black J.L., Lammers G.J. Narcolepsy: immunological aspects. Sleep Med Rev 2008, 12:95-107.
9. Black J.L., Silber M.H., Krahn L.E., Avula R.K., Walker D.L., Pankratz V.S., et al. Studies of humoral immunity to preprohypocretin in human leukocyte antigen DQB1*0602-positive narcoleptic subjects with cataplexy. Biol Psychiatry 2005, 58:504-509.
10. De la Herran-Arita A.K., Kornum B.R., Mahlios J., Jiang W., Lin L., Hou T., et al. CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza a epitope in narcolepsy. Sci Transl Med 2013, 5:216ra176.
11. Cvetkovic-Lopes V., Bayer L., Dorsaz S., Maret S., Pradervand S., Dauvilliers Y., et al. Elevated tribbles homolog 2-specific antibody levels in narcolepsy patients. JClin Invest 2010, 120:713-719.
12. Zhang Y., Davis J.L., Li W. Identification of tribbles homolog 2 as an autoantigen in autoimmune uveitis by phage display. Mol Immunol 2005, 42:1275-1281.
13. Kawashima M., Lin L., Tanaka S., Jennum P., Knudsen S., Nevsimalova S., et al. Anti-tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy. Sleep 2010, 33:869-874.
14. WHO Statement by WHO director Dr Margaret Chan 11 June 2009, http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/index.html:2013-12-18.
15. Smittskyddsinstitutet The influenza A(H1N1) 2009 pandemic in Sweden 2010, A report from the Swedish WHO national influenza centre. http://www.smittskyddsinstitutet/upload/Publikationer/The-Influenza-A-H1N1-2009-Pandemic-in-Sweden-2009-2010_2011-15-1.pdf%202013-12-18.
16. Läkemedelsverket. Pandemrix - adjuvans (immunstimulerande komponenter). Available from: http://www.lakemedelsverket.se/Alla-nyheter/NYHETER-2009/Pandemrix%96adjuvans-immunstimulerande-komponenter:2013-12-18.
17. Läkemedelsverket The MPA investigates reports of narcolepsy in patients vaccinated with Pandemrix 2010, http://www.lakemedelsverket.se/english/All-news/NYHETER-2010/The-MPA-investigates-reports-of-narcolepsy-in-patients-vaccinated-with-Pandemrix:2013-12-18.
18. THL. National Institute for Health and Welfare recommends discontinuation of Pandemrix vaccinations. Available from: http://www.thl.fi/en_US/web/en/pressrelease?id=22930:2013-12-18.
19. Läkemedelsverket. Registerstudie med fokus på neurologiska och immunrelaterade sjukdomar efter vaccination med Pandemrix. Available from: http://www.lakemedelsverket.se/upload/nyheter/2013/PDX%20Rapport%20SV%20-%20registerstudie%207%20landsting%20regioner%202013-03-26.pdf:2013-12-18.
20. Persson I., Granath F., Askling J., Ludvigsson J.F., Olsson T., Feltelius N. Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up. J Intern Med. 2014, 275:172-190.
21. Heier M.S., Gautvik K.M., Wannag E., Bronder K.H., Midtlyng E., Kamaleri Y., et al. Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A 2013, Sleep Med.
22. Partinen M., Saarenpaa-Heikkila O., Ilveskoski I., Hublin C., Linna M., Olsen P., et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PloS One 2012, 7:e33723.
23. Szakacs A., Darin N., Hallbook T. Increased childhood incidence of narcolepsy in western Sweden after H1N1 influenza vaccination. Neurology 2013, 80:1315-1321.
24. Lindberg B., Ahlfors K., Carlsson A., Ericsson U.B., Landin-Olsson M., Lernmark A., et al. Previous exposure to measles, mumps, and rubella-but not vaccination during adolescence-correlates to the prevalence of pancreatic and thyroid autoantibodies. Pediatrics 1999, 104:e12.
25. Svensson M., Ramelius A., Nilsson A.L., Delli A.J., Larsson H.E., Carlsson A., et al. Antibodies to influenza virus A/H1N1 hemagglutinin in type 1 diabetes children diagnosed before, during and after the Swedish A(H1N1)pdm09 vaccination campaign 2009-2010. Scand J Immunol. 2013 Dec 9, [Epub ahead of print]. 10.1111/sji.12138.
26. Grubin C.E., Daniels T., Toivola B., Landin-Olsson M., Hagopian W.A., Li L., et al. Anovel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994, 37:344-350.
27. Payton M.A., Hawkes C.J., Christie M.R. Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). JClin Invest 1995, 96:1506-1511.
28. Jensen R.A., Agardh E., Lernmark A., Gudbjornsdottir S., Smith N.L., Siscovick D.S., et al. HLA genes, islet autoantibodies and residual C-peptide at the clinical onset of type 1 diabetes mellitus and the risk of retinopathy 15 years later. PloS One 2011, 6:e17569.
29. Link J., Kockum I., Lorentzen A.R., Lie B.A., Celius E.G., Westerlind H., et al. Importance of human leukocyte antigen (HLA) class I and II alleles on the risk of multiple sclerosis. PloS One 2012, 7:e36779.
30. Thebault S., Vincent A., Gringras P. Narcolepsy and H1N1 vaccination: a link?. Curr Opin Pulm Med 2013, 19:587-593.
31. Mahlios J., De la Herran-Arita A.K., Mignot E. The autoimmune basis of narcolepsy. Curr Opin Neurobiol 2013, 23:767-773.
32. Han F., Lin L., Warby S.C., Faraco J., Li J., Dong S.X., et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol 2011, 70:410-417.
33. Dauvilliers Y., Montplaisir J., Cochen V., Desautels A., Einen M., Lin L., et al. Post-H1N1 narcolepsy-cataplexy. Sleep 2010, 33:1428-1430.
34. Morel S., Didierlaurent A., Bourguignon P., Delhaye S., Baras B., Jacob V., et al. Adjuvant system AS03 containing alpha-tocopherol modulates innate immune response and leads to improved adaptive immunity. Vaccine 2011, 29:2461-2473.
35. Rouleau I., De Serres G., Drolet J.P., Skowronski D.M., Ouakki M., Toth E., et al. Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1pdm09) vaccine. Vaccine. 2013, 31:5989-5996.
36. Waddington C.S., Walker W.T., Oeser C., Reiner A., John T., Wilkins S., et al. Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study. BMJ 2010, 340:c2649.
37. Fox C.B., Baldwin S.L., Duthie M.S., Reed S.G., Vedvick T.S. Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsions. Vaccine 2011, 29:9563-9572.
38. Singh A.K., Mahlios J., Mignot E. Genetic association, seasonal infections and autoimmune basis of narcolepsy. J Autoimmun. 2013, 43:26-31.
39. Unutmaz D., Pileri P., Abrignani S. Antigen-independent activation of naive and memory resting T cells by a cytokine combination. JExp Med 1994, 180:1159-1164.
40. Mignot E., Lin L., Rogers W., Honda Y., Qiu X., Lin X., et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 2001, 68:686-699.
41. Lim A.S., Scammell T.E. The trouble with tribbles: do antibodies against TRIB2 cause narcolepsy?. Sleep 2010, 33:857-858.